Filament BioSolutions Partners with Canadian Academic Centers to Study Precision Nutritional Therapies

Filament BioSolutions Partners with Canadian Academic Centers to Study Precision Nutritional Therapies
Filament BioSolutions announced a partnership with the University of Ottawa and the Children’s Hospital of Eastern Ontario (CHEO) to conduct a $7.4 million study of clinical applications of microbiome-based precision nutrition for treating inflammatory bowel disease (IBD). Filament is a clinical nutrition company developing therapeutic nutrition products to improve patient health. In this project, Filament will support the development of nutrition-based therapies that use resistant starch for the targeted regulation of gut bacteria in IBD. The grant will fund the development of patient-specific treatment r
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *